Day: October 21, 2024

Amsterdam and Dubai, 21 October 2024: VEON Ltd. (Nasdaq: VEON; Euronext Amsterdam: VEON), a global digital operator (“VEON” or the “Company”), acknowledges the receipt of a letter from Shah Capital (the “Shah Letter”), a valued long-term shareholder holding approximately 7% of VEON’s shares, to the VEON Board of Directors (“VEON Board”). The letter, which outlines Shah Capital’s views on VEON’s current valuation and suggests a seven-step strategic roadmap to enhance shareholder value, has been reviewed by VEON’s Board of Directors and the Management team. VEON thanks Shah Capital for their continued support and feedback; and welcomes the opportunity to address the issues highlighted in the Shah Letter, initially with a response from VEON Board to Shah Capital shared earlier today, and also in the longer term through continued communication.  ...

VANCOUVER, British Columbia, Oct. 21, 2024 (GLOBE NEWSWIRE) — Hi-View Resources Inc. (‘Hi-View’ or the ‘Company’) (CSE: HVW; OTCQB: HVWRF; FSE: B63) is pleased to announce it is launching a non-brokered private placement of up to 5,000,000 units (the “Units”), at a price of $0.02 per Unit for gross proceeds of up to $100,000 (the “Offering”). The Units will consist of one common share of the Company (“Share”) and one share purchase warrant (“Warrant”). Each Warrant will be exercisable by the warrant holder to acquire one (1) additional Share at a price of CAD$0.05 for a period of 24 months from the closing of the Offering. Hi-View will use the net proceeds from the Offering for general working capital. The issuance of securities in connection with this Offering will be subject to Canadian Securities...

WARREN, N.J., Oct. 21, 2024 (GLOBE NEWSWIRE) — Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, reported last week that Chief Scientific Officer (CSO) Dr. Neal Flomenberg sold shares. Tevogen’s Chief Financial Officer, Kirti Desai, clarified that the sale was made solely to satisfy the payment of tax obligations relating to the vesting of restricted stock units and was not made at the discretion of the CSO. Other officers, the Chief Executive Officer, the Chief Financial Officer, and the Chief Commercial Officer, who hold more than 75% of total outstanding shares in aggregate, have already paid taxes when shares were granted and have no further...

Amsterdam and Dubai, 21 October 2024: VEON Ltd. (Nasdaq: VEON; Euronext Amsterdam: VEON), a global digital operator (“VEON” or the “Company”), today announces that it has commenced the process for the delisting of its common shares from trading on Euronext Amsterdam (the “Euronext Amsterdam Delisting”), following the approval of Euronext Amsterdam. The Company’s last day of trading on Euronext Amsterdam will be 22 November 2024 (the “Last Trading Date”) and the delisting will be effective from 25 November 2024. With this move, VEON will consolidate the trading of its shares on the Nasdaq Capital Market (“Nasdaq”), which will be the platform for the trading of VEON’s American depositary shares, each representing 25 Common Shares (the “ADSs”). Following the Last Trading Date, all public trading of equity securities in the Company will take...

Fossar fjárfestingarbanki hf. hefur lokið sölu á nýjum skuldabréfaflokki FOS 281026 sem gefinn er út undir 12.000.000.000 útgáfuramma bankans. FOS 281026 er almennur skuldabréfaflokkur sem ber 9,2% vexti, sem greiddir eru tvisvar á ári til lokagjalddaga 28. október 2026. Seld voru skuldabréf að nafnverði 1.500 m.kr. á ávöxtunarkröfunni 9,48%. Skuldabréfin voru seld í einkaútgáfu (e. private placement). Nafnverðseining skuldabréfanna er 20 m.kr. og var útboðið því undanþegið gerð lýsingar á grundvelli c og d-liðar 4. mgr. 1. gr. reglugerðar Evrópusambandsins og ráðsins (ESB) nr. 2017/1129. Stefnt er að töku skuldabréfanna til viðskipta á markaði Nasdaq Iceland. Markaðsviðskipti Fossa fjárfestingarbanka hf. hafa umsjón með útgáfu og sölu skuldabréfanna sem og töku þeirra til viðskipta á markaði Nasdaq Iceland. Grunnlýsing, endanlegir skilmálar...

ZUG, Switzerland, Oct. 21, 2024 (GLOBE NEWSWIRE) —Phase 3 DIAMOND-1 and DIAMOND-2 trials enrollment of OCS-01 in diabetic macular edema (DME) accelerated with great momentum DIAMOND program committees expanded with globally renowned retina expertsIf approved, OCS-01 has the potential to transform the treatment paradigm as the first topical eye drop to treat DMEOculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announces the acceleration of patient enrollment for both Phase 3 DIAMOND trials of OCS-01 eye drops in DME and expansion of the DIAMOND program committees with globally renowned retina experts. Substantial enrollment progress was achieved since the end of Q2 2024 through early October, with ~70% of patients enrolled in the Phase...

Volta Finance Limited (VTA / VTAS)September 2024 monthly report NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, IN WHOLE OR PART, IN OR INTO THE UNITED STATES Guernsey, October 21st, 2024 AXA IM has published the Volta Finance Limited (the “Company” or “Volta Finance” or “Volta”) monthly report for September 2024. The full report is attached to this release and will be available on Volta’s website shortly (www.voltafinance.com). Performance and Portfolio Activity Dear investors, Volta Finance recorded a net performance of +2.3% in September bringing the year-to-date return to +13.5%. This positive performance is built on the strong performance of its CLO equity investments through the month, Volta being almost fully invested in CLO Equity and debt tranches. Markets found some momentum in September on the back of a rather constructive macro...

NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) — Total assets under management (AUM) at the world’s 500 largest asset managers reached USD 128.0 trillion at the end of 2023, according to new research from leading global advisory, broking and solutions company WTW’s (NASDAQ: WTW) Thinking Ahead Institute. Despite not yet reaching 2021 levels, this amounts to 12.5% annual growth and marks a significant recovery from the major correction the year before (AUM dropped by $18 trillion in 2022). The research also reveals the continued evolution of active vs. passive assets under management among the largest investment managers. For the first time, passive investment strategies now account for more than one third of AUM among the 500 largest firms (33.7%), though this still leaves almost two thirds of assets managed by the world’s largest managers...

Shareholders Approve The New Strategy And Instalment of new Board Schiltigheim, October 21th 2024 18:00, Tonner Drones is pleased to announce that all resolutions has passed during the General Meeting of shareholders today. With 26,92% of the share capital present, the quorum was reached. All resolutions were passed with a large majority of the votes. From today, David Cloetingh and Olaf Graeff have been installed on the new board. Also, the extension of the articles of association was approved by shareholders. This allows TonnerDrones to roll out its new investment strategy. The documentation from the OEGM will be published on the website of Tonner Drones. About Tonner Drones: Tonner Drones (formerly Delta Drone) develops technologies for the logistics sector and has a promising product for stabilizing drones after recoil. Tonner Drones...